A retrospective audit of neonatal BCG vaccination in Grampian, Scotland
ABSTRACTBacillus Calmette–Guerin (BCG) vaccine confers protection against tuberculosis (TB) and works most effectively when given to infants. Scotland runs a risk-based program in which BCG vaccine is offered to infants whose parent or grandparent was born in a high incidence country for TB. BCG vac...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2023.2281737 |
| _version_ | 1797352541728538624 |
|---|---|
| author | Saba Savul Susan Duthie |
| author_facet | Saba Savul Susan Duthie |
| author_sort | Saba Savul |
| collection | DOAJ |
| description | ABSTRACTBacillus Calmette–Guerin (BCG) vaccine confers protection against tuberculosis (TB) and works most effectively when given to infants. Scotland runs a risk-based program in which BCG vaccine is offered to infants whose parent or grandparent was born in a high incidence country for TB. BCG vaccination records for all infants born in Grampian from 1st January 2019 to 31st December 2021 were reviewed from Nov 2022 to Feb 2023. Three electronic databases were examined, i.e. BadgerNet, Scottish Immunisation Recall System and TrakCare. Data were analyzed using Microsoft Excel 2013. Out of a total of 16,078 live births in the 3-year study period, 2060 met the criteria for offering BCG vaccination. The uptake level was 93% in 2019, 89% in 2020 (in the midst of the COVID-19 pandemic) and 93% in 2021. Audit results demonstrated higher uptake than the 85% key performance indicator target within the 2018 Scottish TB Framework and improvement in vaccination rates as compared to earlier rates of 86% in 2012 and 90% in 2013 in Grampian. Strengthening electronic systems and enhancing awareness regarding TB and the BCG vaccine can further progress BCG vaccination uptake. |
| first_indexed | 2024-03-08T13:17:03Z |
| format | Article |
| id | doaj.art-2a160aca050a44d180bff50a4b924de5 |
| institution | Directory Open Access Journal |
| issn | 2164-5515 2164-554X |
| language | English |
| last_indexed | 2024-03-08T13:17:03Z |
| publishDate | 2023-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj.art-2a160aca050a44d180bff50a4b924de52024-01-18T04:53:37ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2023-12-0119310.1080/21645515.2023.2281737A retrospective audit of neonatal BCG vaccination in Grampian, ScotlandSaba Savul0Susan Duthie1Public Health, NHS Grampian, Aberdeen, UKPublic Health, NHS Grampian, Aberdeen, UKABSTRACTBacillus Calmette–Guerin (BCG) vaccine confers protection against tuberculosis (TB) and works most effectively when given to infants. Scotland runs a risk-based program in which BCG vaccine is offered to infants whose parent or grandparent was born in a high incidence country for TB. BCG vaccination records for all infants born in Grampian from 1st January 2019 to 31st December 2021 were reviewed from Nov 2022 to Feb 2023. Three electronic databases were examined, i.e. BadgerNet, Scottish Immunisation Recall System and TrakCare. Data were analyzed using Microsoft Excel 2013. Out of a total of 16,078 live births in the 3-year study period, 2060 met the criteria for offering BCG vaccination. The uptake level was 93% in 2019, 89% in 2020 (in the midst of the COVID-19 pandemic) and 93% in 2021. Audit results demonstrated higher uptake than the 85% key performance indicator target within the 2018 Scottish TB Framework and improvement in vaccination rates as compared to earlier rates of 86% in 2012 and 90% in 2013 in Grampian. Strengthening electronic systems and enhancing awareness regarding TB and the BCG vaccine can further progress BCG vaccination uptake.https://www.tandfonline.com/doi/10.1080/21645515.2023.2281737Tuberculosis preventionbacille Calmette–Guerin vaccineimmunization programsneonatalBCG immunization |
| spellingShingle | Saba Savul Susan Duthie A retrospective audit of neonatal BCG vaccination in Grampian, Scotland Human Vaccines & Immunotherapeutics Tuberculosis prevention bacille Calmette–Guerin vaccine immunization programs neonatal BCG immunization |
| title | A retrospective audit of neonatal BCG vaccination in Grampian, Scotland |
| title_full | A retrospective audit of neonatal BCG vaccination in Grampian, Scotland |
| title_fullStr | A retrospective audit of neonatal BCG vaccination in Grampian, Scotland |
| title_full_unstemmed | A retrospective audit of neonatal BCG vaccination in Grampian, Scotland |
| title_short | A retrospective audit of neonatal BCG vaccination in Grampian, Scotland |
| title_sort | retrospective audit of neonatal bcg vaccination in grampian scotland |
| topic | Tuberculosis prevention bacille Calmette–Guerin vaccine immunization programs neonatal BCG immunization |
| url | https://www.tandfonline.com/doi/10.1080/21645515.2023.2281737 |
| work_keys_str_mv | AT sabasavul aretrospectiveauditofneonatalbcgvaccinationingrampianscotland AT susanduthie aretrospectiveauditofneonatalbcgvaccinationingrampianscotland AT sabasavul retrospectiveauditofneonatalbcgvaccinationingrampianscotland AT susanduthie retrospectiveauditofneonatalbcgvaccinationingrampianscotland |